Elizabeth Swisher

Professor

University of Washington

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (6)

Goldie Lui

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

jordan Berlin

Professor

Vanderbilt University Medical Center

UNITED STATES

View details

Alexandra S. Zimmer

UNITED STATES

View details

Andrew Nixon

Duke University Medical Center

UNITED STATES

View details

Tan Ince

Professor

Weill Cornell Medicine

UNITED STATES

View details

Barbara Norquist

Assistant Professor

University of Washington

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Elizabeth Swisher

Research Interests

Explore related searches

Contact this professor

Articles (11)

The CHK1 inhibitor prexasertib in BRCA wild-type platinum-resistant recurrent high-grade serous ovarian carcinoma: a phase 2 trial

BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor–resistant BRCA -mutant ovarian cancer

An Accessible Communication System for Population-Based Genetic Testing: Development and Usability Study

Using Social Media to Facilitate Communication About Women’s Testing: Tool Validation Study

Randomized Phase II Study of PARP Inhibitor ABT-888 (Veliparib) with Modified FOLFIRI versus FOLFIRI as Second-line Treatment of Metastatic Pancreatic Cancer: SWOG S1513

PolyG-DS: An ultrasensitive polyguanine tract–profiling method to detect clonal expansions and trace cell lineage

Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2)

Targeting BET Proteins BRD2 and BRD3 in Combination with PI3K-AKT Inhibition as a Therapeutic Strategy for Ovarian Clear Cell Carcinoma

Long-term survival of an ovarian cancer patient harboring a RAD51C missense mutation

Combination of PARP Inhibitor Olaparib, and PD-L1 Inhibitor Durvalumab, in Recurrent Ovarian Cancer: a Proof-of-Concept Phase II Study

Rare BRIP1 Missense Alleles Confer Risk for Ovarian and Breast Cancer

Collaborators (6)

Goldie Lui

jordan Berlin

Alexandra S. Zimmer

Andrew Nixon

Tan Ince

Barbara Norquist

Make your next move.